Literature DB >> 25987552

Extracorporeal life support for massive pulmonary embolism during pregnancy.

A Bataillard1, A Hebrard2, L Gaide-Chevronnay2, M Casez2, G Dessertaine2, M Durand2, O Chavanon2, P Albaladejo2.   

Abstract

Massive pulmonary embolism is a leading cause of death during pregnancy. While the prevention of thromboembolic disease during the peripartum period is codified, there is no consensus regarding its treatment. We report two cases of pregnant women who had massive pulmonary embolisms (PE) and shock treated with veno-arterial extracorporeal life support (ECLS) and heparin therapy.Haemodynamic and oxygenation parameters were rapidly restored. The patients completely recovered and the pregnancies continued. The patients did not develop pulmonary hypertension. ECLS can be considered as a successful treatment option of massive pulmonary embolism during pregnancy.
© The Author(s) 2015.

Entities:  

Keywords:  extracorporeal life support; pregnancy; pulmonary embolism; thrombolysis; vital distress

Mesh:

Substances:

Year:  2015        PMID: 25987552     DOI: 10.1177/0267659115586578

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  3 in total

Review 1.  Pregnancy and Pulmonary Embolism.

Authors:  Christopher Deeb Dado; Andrew Tobias Levinson; Ghada Bourjeily
Journal:  Clin Chest Med       Date:  2018-09       Impact factor: 2.878

2.  Extracorporeal Life Support in Pregnancy: A Systematic Review.

Authors:  Emily E Naoum; Andrew Chalupka; Jonathan Haft; Mark MacEachern; Cosmas J M Vandeven; Sarah Rae Easter; Michael Maile; Brian T Bateman; Melissa E Bauer
Journal:  J Am Heart Assoc       Date:  2020-06-24       Impact factor: 5.501

3.  A modified Delphi approach to determine current treatment advances for the development of a resuscitation program for maternal cardiac arrest.

Authors:  Andrea D Shields; Jacqueline D Battistelli; Laurie B Kavanagh; Brook A Thomson; Peter E Nielsen
Journal:  BMC Emerg Med       Date:  2022-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.